As a leading provider of services to Covered Entities participating in the 340B Drug
Pricing Program, Wellpartner is committed to identifying and analyzing all of the key
issues affecting the Program, and sharing our point of view with you. Being at the
forefront of change positions Wellpartner and our clients to positively influence the
future, as well as prepare for it.